VolitionRx Announces First Peer-Reviewed Publication On Capture-Seq Liquid Biopsy Technology; Says It Is In Active Licensing Discussions Targeting $36B Combined MCED And MRD Market

Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results

US stocks traded higher with Nasdaq up 200 points. Dow down 0.01%, Nasdaq up 0.77%, and S&P 500 up 0.27%. Tech shares rose 2.2% while consumer staples fell 1.1%. Nvidia reported strong earnings. Propanc Biopharma up 211%, VolitionRX up 86%, Mint Incorporation up 74%, Alpha Modus down 25%, Change Agents down 29%, and Xiao-I down 21%.

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations

VolitionRx reports 112% revenue growth in H1 2026 while advancing its Nu.Q diagnostic platforms across sepsis and oncology markets.

Why Salesforce Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Salesforce Inc (NYSE: CRM) stock rose on good Q2 results and raised FY27 guidance, while other tech stocks saw gains in early trading.Salesforce (NYSE: CRM) jumps on strong Q2 results and raised guidance, tech stocks up in pre-market trading.

VolitionRx shares are trading lower. The company announced the publication of a peer‑reviewed paper and editorial showing its Nu.Q NETs H3.1 biomarker predicts 28‑day mortality and need for renal replacement therapy in sepsis patients.